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Micronutrient deficiency persists throughout the world, and while the burden is higher in low 
resource settings, it is also prevalent in wealthy countries, a phenomenon termed ‘hidden 
hunger’. Due to their high requirements for vitamins and minerals relative to their energy 
intake, young women and children are particularly vulnerable to hidden hunger. As they 
share several risk factors and impact on overlapping outcomes, we consider how deficiency 
of iron, iodine and vitamin D can have profound impacts on perinatal health and infant 
development. We review the epidemiology of these micronutrient deficiencies during 
pregnancy, including social, environmental and dietary risk factors. We identify the main 
challenges in defining nutritional status of these nutrients using validated diagnostic criteria 
linked with meaningful clinical outcomes. Public health strategies are urgently required to 
improve the overall health and nutritional status of women of reproductive age. Obesity 
prevention and early detection of malnutrition with standardised screening methods would 
detect pregnant women at increased risk of iron deficiency. Development of sensitive, 
individual biomarkers of iodine status are required to protect maternal health and fetal/infant 
brain development. Risk assessments of vitamin D requirements during pregnancy need to be 
revisited from the perspective of fetal and neonatal requirements. International consensus on 
standardised approaches to micronutrient assessment, analysis and reporting as well as 
sensitive, clinically-validated infant and child neuro-behavioural outcomes will enable 









Globally, it is estimated that 1 in 4 people (~2 billion) lack the essential micronutrients to 
grow, develop and maintain health and function 
(1)
. Micronutrients have fundamental roles in 
fetal weight gain, brain development, immune regulation and musculoskeletal growth and are 
central modulators of multi-system and organ development 
(2)
. Although micronutrient 
deficiencies are widespread in low-middle income countries, they are also prevalent in high-
resource settings; a phenomenon termed ‘hidden hunger’ 
(3)
. Due to their high requirements 
for vitamins and minerals, young women and children are particularly vulnerable to 
micronutrient malnutrition 
(1)
. Awareness of the importance of a woman’s health and 
nutritional status prior to pregnancy is low and there is enormous scope to improve 
preconception health at a population level 
(4)
. However, progress in resolving the burden of 
micronutrient malnutrition is slow, and as nutrient deficiencies are underlying factors in the 
development of both acute and chronic illnesses, failure to address vitamin and mineral 





This paper focuses on three nutrients that have been identified as concerning during 
pregnancy; iron, iodine and vitamin D. As they share several risk factors and impact in 
different ways on overlapping outcomes, particularly neurological development, it is 
appropriate to consider how deficiency of these nutrients can have profound impacts on 
pregnancy outcome and fetal and infant development, health and life chances. Often 
discussed, micronutrient deficiency among young women prior to and during pregnancy is 
essentially neglected in terms of programmatic research support, policy development and 
implementation of measures to prevent low intakes and status.  
 
The aim of this paper, arising from a presentation by the first author at the Nutrition Society 
Winter Meeting of 2020, is to review the evidence for malnutrition during pregnancy of iron, 
iodine and vitamin D, including non-nutritional and nutritional risk factors and health 
outcomes associated with deficiency. Emerging data on neurological development and 
challenges in defining nutritional status, linked to validated health outcomes, are discussed. 
This paper is not a systematic review, but an evaluation of available evidence for the 
purposes of public health nutrition and clinical practice and to identify knowledge gaps. 
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Iron deficiency is the most common micronutrient deficiency in the world and pregnant 
women are vulnerable 
(6)
. Almost 1000 mg of iron must be acquired during pregnancy to 
support an increased maternal plasma and blood volume, the increased oxygen and iron 
demands of the fetus and the iron requirements of the placenta itself 
(7)
. Worldwide, up to 
38% of pregnant women have anaemia, with an even higher prevalence in low-resource 
settings 
(8)
. In Europe, iron deficiency is reported in 28-85% of pregnancies, particularly in 




Risk factors for iron deficiency during pregnancy 
 
Dietary risk factors 
To avoid iron deficiency while pregnant, women must enter pregnancy with sufficiently large 
iron stores and consume a diet abundant in bioavailable iron 
(10)
. Unfortunately, this is not 
always achievable. In Europe, median serum ferritin concentrations of women of 
reproductive age range from 26-38 µg/L, suggesting that 40-50% have depleted iron stores 
(indicated by ferritin ≤30 µg/L, below which no stainable bone marrow hemosiderin iron is 
observed) before becoming pregnant 
(9)
. To further compound this, inadequate iron intakes 
and poor compliance with dietary guidelines are widely reported amongst pregnant women 
worldwide 
(11-13)
; recent European data suggest that 60-100% of women during pregnancy 
had iron intakes below the recommended intake 
(14)
. Pregnant women with poorly managed 
vegetarian and vegan diets 
(15)
 and pregnant adolescents 
(16)
 are at particular risk. 
 
The dietary references values for pregnant and non-pregnant, non-lactating women are 
presented in Table 1, with significant variability between agencies. Recommended intakes 
are the same for pregnant women as for non-pregnant, non-lactating women from the UK’s 
Scientific Advisory Committee on Nutrition 
(17)
 and European Food Safety Authority 
(18)
, 
based on evidence that iron absorption, particularly of non-heme iron, becomes more 
efficient during pregnancy 
(19, 20)
. In contrast, the US Institute of Medicine recommend higher 
intakes of 27mg/d, to be met in part by supplementation, on the basis that the increased 




Non-dietary risk factors 
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Several common pregnancy-related conditions and maternal lifestyle factors can affect 
maternal-fetal iron supply in utero, resulting in an increased risk of iron deficiency in the 
mother, her fetus or most likely both, even if dietary supply is adequate. Relative to first-time 
and singleton pregnancies, women who have had several pregnancies or expecting more than 
one baby are at increased risk of iron deficiency during pregnancy 
(22, 23)
. Iron deficiency can 
also occur in the mother and fetus as a result of conditions that decrease fetal iron delivery 
and/or increase fetal iron demand beyond the transport capacity of the placenta 
(24)
. 
Gestational diabetes mellitus (GDM), hypertension and maternal smoking all induce 
intrauterine fetal hypoxia, limiting the oxygen supply to the fetus, resulting in increased 
erythropoiesis, exceeding the system’s capacity and increasing the risk of iron deficiency 
(25-
27)
. Worryingly, these conditions, particularly GDM, have been shown to have lasting 




Obesity in women who enter pregnancy is associated with adverse health consequences for 
both mother and infant 
(30)
. However, until recently, the impact of maternal obesity on 
maternal and fetal iron status was widely unacknowledged.  Poorer iron status and an 
increased risk of iron deficiency have been reported in pregnant women who were obese 
prior to or during pregnancy 
(31-34)
. While obese women are likely to have different dietary 
profiles to non-obese women, maternal obesity is thought to result in iron deficiency in both 
the mother and her infant primarily through the action of the iron regulatory hormone, 
hepcidin. Hepcidin controls the levels of circulating iron in the body through its influence on 
intestinal iron absorption and iron sequestration 
(7)
. In healthy pregnancies, hepcidin 




 trimesters to increase the supply of iron into 
circulation to meet requirements. In pregnancies complicated by obesity, hepcidin may be 
overexpressed as a downstream effect of the low-grade, chronic inflammation associated with 
obesity, inhibiting intestinal iron absorption and the release of iron from body stores 
(35)
. 
Elevated hepcidin and inflammatory marker concentrations have been observed in a number 
of studies in pregnant women 
(31, 32, 35, 36)
, although further consideration is required on the 





Diagnostic criteria for iron deficiency during pregnancy 
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Various biomarkers are available to characterise the different stages of iron status, moving 
from iron depletion to deficiency to iron deficiency anaemia. Haemoglobin is the most 
frequently used of these, due in part to the wide availability of point-of-care tests. However, 
haemoglobin only assesses anaemia, the last stage of iron depletion. This is a concern, as all 
organs of the body become iron deficient before red blood cell indicators are altered 
(28)
. Iron 
supply to the liver, heart, skeletal muscle and perhaps most crucially, the brain, is 
compromised prior to a reduction in haemoglobin concentrations. Ideally, assessment of iron 
status amongst pregnant women should be based on a battery of biomarkers that assess iron 
storage, transport and functional markers. At the very least, assessment of iron status should 
incorporate both serum ferritin and haemoglobin 
(38)
. While much debate exists as to the 
appropriate thresholds to apply to these biomarkers in pregnant women 
(39, 40)
, the WHO 
currently recommends a threshold of <110 g/L for haemoglobin and <15 µg/L for ferritin 
(accounting for inflammation as ferritin is an acute phase reactant). Although further work is 
needed to ensure that these thresholds are related to meaningful clinical outcomes, beyond 
haematological outcomes 
(41)
, application of these thresholds for both markers consistently 
across regions would be a start to defining the scope of the problem. 
 
Health impacts of iron deficiency during pregnancy 
 
Maternal and pregnancy-related 
Once the oxygen carrying-capacity of the blood becomes diminished, pregnant women may 
experience the common anaemia symptoms of paleness, weakness, fatigue and general 
lethargy 
(10)
. However, the consequences of iron deficiency, particularly its end stage of 
anaemia, can be much more severe, resulting in adverse pregnancy and birth outcomes. Low 
haemoglobin in the 1
st
 trimester has been associated with an increased risk of preterm birth 
and low birth weight 
(42-44)







, but a threshold effect exists; moderate to severe, but not mild anaemia, was 
associated with an increased risk of small-for-gestational age in a meta-analysis by Kozuki 
and colleagues 
(45)
. Far fewer studies have explored associations with indices of iron 
deficiency, with conflicting evidence to date from those that have, particularly given the 
confounding impact of inflammation on ferritin 
(46; 47)
. Moreover, the U-shaped curve of risk 
associated with iron status during pregnancy must also be considered, as elevated iron status 
indices, including ferritin and haemoglobin, particularly in the 3
rd
 trimester, have been 
associated with an increased risk of some adverse birth outcomes 
(42, 44, 48)
. Excess iron 
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intakes or elevated iron status during pregnancy is thought to increase blood viscosity, impair 
placental blood flow and contribute to oxidative stress, further emphasising the caution 




Fetal and infant development 
Iron deficiency during pregnancy presents a triple threat for fetal development, but most 
critically, for fetal brain development. Iron is essential for the developing brain, due to its key 
role in the fundamental neuronal processes of neurotransmitter and energy metabolism and 
myelination, summarised in Table 2 
(10, 49)
. An inadequate supply of iron, particularly during 
sensitive periods of critical brain development, can therefore disrupt these fundamental 
processes, with lasting consequences. 
 
Low maternal iron intake and status during pregnancy can present an immediate threat to 
fetal brain development. Low maternal iron intake during the 3
rd
 trimester resulted in altered 
neonatal brain structure, most notably in cortical grey matter 
(50)
 and Schmidt and colleagues 
reported an inverse association between maternal intake and risk of autism spectrum 
disorders in early childhood 
(51)
. In a recent systematic review, Janbek et al. concluded that 
there was some evidence that maternal iron status during pregnancy may be associated with 
offspring behaviour, cognition, and academic achievement, but not motor development 
(52)
. 
However, this research field has significant limitations due to huge variability in study 
design, neurological assessments performed and the timing of both the exposure and outcome 
assessments. The most crucial limitation is the reliance of most studies on haemoglobin to 
assess maternal iron status. A large Spanish birth cohort recently reported higher scores in 
working memory and executive function at 7 years in children whose mothers had serum 






Fetal iron accretion is compromised in mothers with moderate to severe iron deficiency. 
Maternal ferritin concentrations of 12-13.6 µg/L were identified as important thresholds 
below which fetal iron accretion is significantly reduced 
(54, 55)
. Maternal iron deficiency, in 
addition to pregnancy complications including fetal growth restriction and prematurity, 
delivery by Caesarean section and the maternal and pregnancy-related factors we’ve already 
discussed, all increase the risk of neonatal iron deficiency 
(24, 56)
. Neonatal iron deficiency 
itself is associated with abnormalities in the newborn auditory system 
(57, 58)
, poorer 
recognition memory at ~15 days old 
(29)
 and poorer language ability, fine mother skills and 
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tractability at 5 years of age 
(59)
. More recently, in our generally healthy, low-risk maternal–
infant cohort in Ireland, we identified lasting behavioural consequences of neonatal iron 
deficiency in children born to mothers with obesity or delivered by Caesarean section 
(60)
. 
This is especially concerning as early cognitive and social-emotional development are strong 
determinants of future educational attainment, mental health, career and earning potential and 
overall quality of life 
(61, 62)
. As a final threat, infants born iron deficient or with reduced iron 
stores are also at increased risk of continued iron deficiency, as low iron stores at birth track 
through infancy and early childhood 
(63, 64)
. Particularly during the period of critical brain 
development from 6-24 months of age, iron deficiency is associated with irreversible 





Inadequate iron supply in utero, due to iron malnutrition, inflammation, obesity or an 
underlying metabolic disease, presents a massive threat of long-term neurological 
consequences and represents a real cost and burden to individuals and society. Public health 
strategies are urgently required to improve the overall health and nutritional status of women 
of reproductive age, with the rising prevalence of overweight and obesity a major concern 
amongst this population group. Iron sufficiency during pregnancy is essential to ensure the 
health of the mother, improve pregnancy outcomes and protect fetal and infant brain 
development 
(66)
. A dual approach encompassing strategies targeting prevention and early 
detection is required 
(67)
. An enhanced focus on the most effective supplementation strategies 
in pregnant women is also needed, with further consideration of dosing, forms of iron used 
and side effects. Finally, the development of screening strategies to enable early detection of 
pregnant women at increased risk of iron deficiency should be prioritised, with the dual 




Iodine is an essential trace element required for thyroid hormone synthesis. Critical to the 
regulation of basal metabolic rate and macronutrient metabolism, thyroid hormones are also 
fundamental to normal development of the central nervous system via their regulation of cell 
migration, differentiation and myelination 
(68)
. Iodine deficiency disrupts the metabolism of 
thyroid hormones; therefore, adequate iodine status prior to and during pregnancy is critical. 
During pregnancy, the requirement for iodine increases by 50% 
(69)
. This is to enable 
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increased maternal thyroxine production to ensure adequate fetal supply until the fetal thyroid 
can concentrate iodine and produce thyroid hormones, and to supply the placental transfer of 
iodine to support fetal thyroid hormone production. In addition, the increased rate of 
glomerular filtration during pregnancy increases renal clearance of iodine.  
 
Determinants of iodine status 
 
Diet and fortification 
Recognition of country-specific habitual food consumption and iodised salt coverage is 
essential in considering dietary risk factors for low iodine status. Consumption of iodised salt 
is the most influential dietary determinant of iodine intake and status. Recent global estimates 
from UNICEF show that 88% of households consume iodised salt 
(70)
. The highest coverage 
was reported for East Asia and the Pacific and South Asia (92% and 89%, respectively) while 
in Western and Central Africa, 76% of individuals had access to iodised salt. While coverage 
has increased significantly from 70% reported in 2012 
(71)
, it is estimated that 29% of 
countries with data on household penetration met the international goal of at least 90% of 
households consuming adequately iodised salt, while 30% of countries had coverage rates of 
less than 50%. In Europe, 27% of households have iodised salt 
(72)
, but coverage can be as 




In many countries, particularly in those without a salt iodisation policy, milk and dairy 
products make significant contributions to iodine intake and status in women of childbearing 
age 
(74-76)
 and in pregnant women 
(76-80)
. However, a shift in consumption patterns away from 
dairy towards plant-based milks, many of which are not fortified with iodine, may reduce 
iodine intake and increase the risk of iodine deficiency 
(81)
. Consumption of fish and shellfish 
has been associated with iodine status in UK and Spanish pregnant populations 
(78)
, but 
consumption of seafood is typically low among women of childbearing age. 
 
Maternal factors 
Data on the relationship between maternal body mass index (BMI) and iodine status are 
mixed and subject to confounding. In a sample of Thai pregnant women, no differences in 
Urinary Iodine Concentration (UIC) were observed between normal weight and overweight 
women; however, in this group, a BMI ≥23 kg/m
2
 resulted in 3.6-fold higher odds of low 
maternal free thyroxine in the first trimester 
(82)
, which may be reflective of the relationship 
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between adiposity and hypothyroxinaemia, but not necessarily to iodine-related thyroid 
dysfunction. In an analysis of three European cohorts, BMI was negatively associated with 
urinary iodine: creatinine ratio (UI/Creat), but not with UIC 
(78)
, which warrants further 
analysis as BMI is often but not always associated with adiposity. The setting is also an 
important factor to consider in interpreting the relationship between body weight and iodine 
status. In a study of Iranian women by Gargari et al. 
(83)
, the odds of UIC < 150µg/L 
decreased by 13% for every 1kg increase in weight during pregnancy, which the authors posit 
was a proxy indicator of dietary quality. 
 
Maternal age and social factors 
UIC was negatively associated with age in a sample of non-pregnant women in the National 
Health and Nutrition Examination Survey (NHANES (2001/2006)); however, no association 
of UIC with age was observed for pregnant women in the same study 
(76)
. Dineva et al. 
(78)
 
reported that there was a positive association of maternal age with UI/Creat; however, the 
relationship may be confounded by the association of maternal age with dietary patterns and 
iodine-supplement use. In the study by Gargari et al. 
(83)
 other factors such as whether the 
pregnancy was planned, the time since the most recent pregnancy, maternal education level 
and maternal iodine supplement use prior-to and during pregnancy were associated with 
better iodine status. 
 
Assessment of iodine intake and status 
 
Dietary reference values for iodine intake are presented in Table 1. As with all dietary 
assessments, the reliability of an estimate of nutrient intake is largely dependent on the 
quality of the food composition data 
(84)
. Iodine food data represent a challenge due to 
incomplete data and natural variability in iodine content of food, which varies with season 
and as a result of agricultural practices. Further, the iodine content of soil varies considerably 
across regions 
(85)
 due to geological factors 
(86)
. Currently, food composition datasets do not 
provide any information on the variability of iodine content within foods. Utilisation of a 
probabilistic modelling approach to account for variability in iodine food composition may 
overcome this challenge and improve the validity and reliability of iodine intake assessments. 
 
UIC directly reflects dietary iodine intake and is the most common indicator used worldwide 
to assess population iodine status. The population median UIC is assessed against the 
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reference range for adequacy for pregnant women of 150 – 249 µg/L 
(87)
. However, one of the 
major challenges of the iodine field is the absence of an individual biomarker of iodine status. 
While it is useful at a population level, UIC is heavily influenced by day-to-day variation in 
water and protein intakes, making it inappropriate for assessing individual iodine status 
(86)
. 
To identify mild-to-moderate iodine deficiency, biomarkers of individual iodine status are 
urgently required. In recent years, thyroid hormones have been proposed as functional 
markers of iodine status. However, although triiodothyronine, thyroxine and TSH are thyroid 
functional measures, tight homeostatic regulation makes them unsuitable as markers of iodine 
status, as values can remain in the normal reference range in individuals with low iodine 
intake 
(89)
. Thyroglobulin (Tg), a thyroid-derived protein that reflects thyroid volume in both 
iodine-deficient and iodine sufficient population groups, has shown promise as a functional 
biomarker of iodine status 
(90)
 and further assessment of its usefulness is ongoing. 
 
Epidemiology of iodine deficiency 
 
Iodine deficiency disorders have been described as the leading cause of preventable impaired 
mental function worldwide 
(91)
, estimated to affect 1.88 billion people 
(92)
. In a global analysis 
of UIC in 2011, one in three school-aged children and 28.5% of the general population had 
inadequate iodine intakes 
(93)
. Significant regional differences in prevalence estimates were 
reported, indicating that iodine deficiency is primarily an issue of geography because of 
variability in iodine content of soil and water as well as country- and region-specific 
iodisation policies and dietary patterns. Inadequate iodine intakes were estimated in 44% of 
the WHO Europe region population, where iodised salt penetration is low 
(93)
. In 2017, 
pregnant women in 39 of 72 countries with UIC data had suboptimal iodine intake where 
median UIC was < 150 µg/L 
(94)
. Of the 40 countries with UIC data in both school-aged 
children and pregnant women, 29 countries reported deficiency in the women and sufficiency 
in the children, highlighting the limitation of using school-aged children UIC as a proxy of 





Health and developmental impacts of maternal iodine deficiency 
 
Maternal iodine deficiency can have important clinical consequences for the mother and her 
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Prior to conception, severe iodine deficiency has been associated with reduced fecundity in 
women of childbearing age 
(97)
. During pregnancy, severe iodine deficiency may result in 
increased risk of miscarriage and stillbirth 
(98)
. Neonatal consequences of severe maternal 
iodine deficiency are profound and most severely can manifest as cretinism, characterised by 
severe mental impairment with squint, deaf mutism and motor defects. Severe maternal 





The adverse effects of mild-to-moderate iodine deficiency are less clear. Maternal iodine 
status has been associated with child neurological outcomes in some 
(100-105)
, but not all 
observational studies 
(106-108)
. Levie and colleagues 
(109)
 conducted a recent meta-analysis of 
individual participant data in three large European birth cohorts (n = 6180) 
(110-112)
. They 
reported a curvilinear relationship of UI/Creat with lower verbal but not non-verbal IQ 
scores. Gestational age at urine sampling was identified as a significant effect modifier of the 
association of UI/Creat with verbal IQ scores. In stratified analyses, UI/Creat in the first 12 
weeks of pregnancy was associated with an overall effect of 5 IQ points; between 12-14 
weeks gestation, UI/Creat showed a linear association with verbal IQ, with an overall effect 
of 3 IQ points and no association was observed after 14 weeks of gestation. Taken together, 
these data signpost a critical period for iodine-related (thyroid hormone-mediated) 
neurological development early in the first trimester. However, a recent systematic literature 
review and meta-analysis of the effects of iodine supplementation on thyroid function and 
child outcomes has shown that there is insufficient good-quality evidence to support 
recommendations for iodine supplementation in pregnancy in areas of mild-to-moderate 
deficiency 
(113)
. The authors suggest that the inconsistencies in the evidence may be 
attributable to maternal iodine status prior to pregnancy or on study entry, the dose and form 




There is mounting evidence that low to zero consumption of iodised salt, coupled with a shift 
away from dairy consumption as well as low seafood intakes among young women is 
contributing to low intakes of iodine. However, the nature and extent of the impact of this 
deficit on perinatal and child outcomes is unclear. If we are to clarify the nature of the 
relationship between maternal iodine status and offspring development and develop point-of-
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care screening to support timely intervention, we must prioritise the development of valid 
biomarkers of individual iodine status. Investment in food composition data and global co-
operation to develop standardised approaches to using composition data with variability 
inherent in the estimates of nutrient exposure are also required. Well-designed and well-timed 
observational studies and intervention studies accounting for maternal iodine status in early 
gestation, or prior to pregnancy, with sensitive, clinically validated infant and child neuro-




The classical role of vitamin D in maintaining bone health is well-described and much 
attention in the vitamin D field has shifted towards understanding its role in non-skeletal 
health outcomes, particularly in relation to immune function, non-communicable diseases and 
fetal and infant development 
(114)
. During early pregnancy, vitamin D metabolism changes; 
vitamin D binding protein concentrations increase and increases in 1--hydroxylase activity 
in the maternal kidney, placenta and decidua 
(115)
 lead to circulating 1,25-dihydroxyvitamin D 
(1,25(OH)2D) concentrations that are 2-3 times higher than usual by 12 weeks of gestation, 
with relatively stable serum 25(OH)D 
(116)
. These metabolic shifts appear to be unrelated to 
calcium metabolism and are not maintained during lactation. There are compelling data to 
support the possibility that 1,25(OH)2D, a potent immune modulator, is necessary for 
successful pregnancy implantation by adapting the immune response, creating an anti-
inflammatory milieu and enabling fetal growth 
(117, 116)
. There is plenty of evidence that 
25(OH)D crosses the placenta and infants are born with circulating 25(OH)D concentrations 




Epidemiology of vitamin D deficiency 
 
The problem of endemic low vitamin D status in many parts of the world is multifactorial. 
Low sunshine availability due to latitude, weather, air pollution, skin exposure or clothing 
practices, or a reduced ability to synthesise cholecalciferol from UVB due to skin colour, age 
or genetics 
(120)
, mean that large sectors of the global population rely on vitamin D in the food 
supply to maintain adequate vitamin D status. Naturally occurring sources of vitamin D, such 
as oily fish, are consumed irregularly and in low quantities, and global food fortification 
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0029665121001944





, contributing to low habitual vitamin D intakes among many populations 
(122)
. Supplementation recommendations rely on individual compliance for their effectiveness 
and uptake is highly variable, particularly in low- and middle-income settings 
(123)
. Low 
vitamin D status, denoted in this paper by a circulating 25-hydroxyvitamin D (25(OH)D) 
concentration below 50 nmol/L and vitamin D deficiency, designated as 25(OH)D < 25/30 
nmol/L, can also arise as a consequence of underlying health issues, frailty, inflammation, 




Vitamin D deficiency and low vitamin D status among pregnant women 
In a recent systematic review, Mogire et al 
(124)
 reported the prevalence of serum 25(OH)D 
<75 nmol/L, 50 nmol/L and 30 nmol/L across Africa. Among 133 studies including 21,591 
participants from 23 African countries, the prevalence of 25(OH)D < 50 nmol/L was 34·4% 
and 18·5% were <30 nmol/L. Countries in the north of Africa and urban South Africans were 
most at risk, particularly women and new-born infants. Three studies of pregnant women (in 
Ethiopia, South Africa and Tunisia) with a total sample of 408 reported that 53% had a serum 
25(OH)D < 30 nmol/L and among 10 studies with 975 participants, 44% were below 50 
nmol/L. This high prevalence of deficiency and low vitamin D status among many women in 
Africa is concerning, particularly considering the low calcium intakes in many regions across 
the continent 
(125,126)




The first internationally standardised European 25(OH)D dataset, directly comparable to data 
from the US and Canada, was reported in 2016 
(128)
. The overall prevalence of 25(OH)D < 30 
nmol/L was 13%, about twice that of the US (5.9%) 
(129)
 and Canada (7.4%) 
(130)
, but persons 
of ethnic minority were at much higher risk than their white counterparts (36-60% of BAME 
individuals in the UK and 65% of South Asian participants in Norway). Among 83 low- and 
middle-income countries (LMIC), only 29 had population-based assessments of 25(OH)D 
(131)
. Afghanistan, Pakistan, India, Tunisia, Syria, the West Bank and Gaza and Mongolia 
were classified as “hot spots” for very low vitamin D status (<25-30 nmol/L) among women, 
pregnant women or infants on the basis of having a prevalence > 20%. Largely attributed to 
clothing practices, it has been noted that women and girls in low income and middle eastern 
countries in particular have lower 25(OH)D than their male counterparts 
(132, 133)
. Conclusions 
and strategies to address the problem are limited by the quality of the available evidence in 
many countries and the under-representation of minority groups in clinical research 








Palacios and Gonzales 
(135) 
described a high prevalence (>20%) of 25(OH)D <30 nmol/L 
among pregnant women and infants in many countries, including South Asia and the Middle 
East. Up to 60% of women in India and 86% of infants in Iran had 25(OH)D < 30 nmol/L. 
Saraf and colleagues 
(136) 
estimated the global prevalence of 25(OH)D concentrations < 50 
nmol/L at 54% among pregnant women and 75% among new-born infants, with almost one 
in five pregnant women and one in three new-borns below 25 nmol/L. Studies among 
pregnant women from ethnic minorities in Wales 
(137)











consistently report a high prevalence of vitamin D deficiency. Using gold standard 25(OH)D 





we reported a prevalence of 17% with 25(OH)D < 30 nmol/L at 15 weeks 
of gestation; this was 49% among women of ethnic minority 
(142)
. Among the infants of this 
cohort, 46% of umbilical cord sera had a 25(OH)D < 30 nmol/L; this was 73% among infants 
born to women of ethnic minority 
(143)
. Overall, these prevalence estimates elevate vitamin D 
deficiency among mothers and babies to the status of a serious public health problem that 
requires urgent action. 
 
Implications for perinatal outcomes and fetal/infant development 
 
Increasing mechanistic evidence that vitamin D has a role in the progression of a healthy 
pregnancy supports a biologically plausible hypothesis that vitamin D deficiency may, in 
part, contribute to adverse perinatal outcomes resulting from growth restriction, hypertension 
or pre-eclampsia 
(118, 144)
. Neurological development is a potential consequence of vitamin D 
deficiency in early life. Eyles and colleagues have mapped the presence of the vitamin D 
receptor and 1--hydroxylases throughout brain tissues and have developed in vitro and 
animal models that describe the many ways in which maternal and offspring vitamin D 
deficiency exerts detrimental effects on behaviour 
(145)
. Vitamin D metabolites have also been 
shown to cross the blood-brain barrier 
(146) 
and it is also worth noting that growth restriction 
itself, also associated with vitamin D deficiency 
(142)
 adversely impacts neurological 
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We did not find any association with maternal or cord 25(OH)D and cognitive or behavioural 
outcomes at 5 years in a well-characterised low-risk prospective mother-infant cohort 
(148)
. 
Our analysis of the existing literature at the time showed conflicting signals, with significant 
heterogeneity in study design, including the timing and methods for exposure and outcome 
assessments, statistical approaches, variable adjustment for known confounders and cut-offs 
for 25(OH)D concentrations 
(148)
. Mutua and colleagues 
(149) 
systematic review of vitamin D 
and neuro-behavioural outcomes in children reached a similar conclusion; following analysis 
of 32 studies among >31,000 participants, the authors recommended standardized cut-offs for 
assessing vitamin D deficiency, as well as well-validated methods of assessing neuro-
behavioural outcomes to allow international harmonisation and comparison of data as well as 
progression of the field into large well-controlled intervention studies. 
 
Vitamin D requirements and dietary recommendations 
 
Several systematic reviews of the role of vitamin D supplementation during pregnancy have 
been published lately 
(150, 151)
 but there is no consensus as to whether vitamin D requirements 
are greater during pregnancy than in non-pregnant women and whether supplementation 
should be recommended. Current dietary requirements for vitamin D were established on the 
basis of skeletal health outcomes, and most agencies have proposed the same adequacy 
thresholds for 25(OH)D and dietary recommendations for vitamin D for pregnant and 
lactating women as non-pregnant adults 
(152-154)
, summarised in Kiely et al 
(155)
 (Table 1).  
 
The question remains therefore: on what basis should vitamin D requirements and dietary 
recommendations during pregnancy be targeted? Fetal and neonatal circulating 25(OH)D 
concentrations are dependent on maternal vitamin D status but dietary recommendations do 
not consider the vitamin D requirement of the developing fetus or newborn infant and assume 
immediate availability of an adequate vitamin D supply from early life to redress deficiency. 
We proposed prevention of neonatal vitamin D status < 25−30 nmol/L, indicated by 
umbilical cord 25(OH)D, as a potential target for defining maternal vitamin D requirements 
during pregnancy, consistent with prevention of nutritional rickets 
(156, 127)
. The vitamin D3 
intake required to maintain maternal 25(OH)D > 50 nmol/L in almost all mothers, which 
ensured that cord sera were all >25nmol/L, was 30 μg/day (1200 IU) 
(156)
. This was consistent 
with other dose-response studies from Canada 
(157)
 and New Zealand 
(158)
. Further similar 
dose-response studies are required in different racial and ethnic groups and in various settings 
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to generate an inclusive estimate of maternal vitamin D requirements for the prevention of 
neonatal deficiency, with adequate consideration of calcium intake 
(159)
. The design and 
protocol for such studies are available and would be a cost-effective approach to ensure safe 
evidence-based antenatal prevention of vitamin D deficiency among mothers and newborn 
infants.  
 
Widespread maternal and neonatal vitamin D deficiency is a present danger requiring 
immediate public health action. Whether there is a role for additional vitamin D over and 
above current dietary recommendations, to support healthy pregnancy and promote optimal 
perinatal outcomes and infant development, is a separate question, which requires further 
investigation in well-designed placebo-controlled randomised trials, discussed separately 
(160)
. 
These issues are often conflated in the literature, leading to confusion and a narrow 
discussion of the core question. For example, the most recent WHO statement on vitamin D 
supplements during pregnancy did not address the most important issue of vitamin D 
deficiency prevention and the grave risk of nutritional rickets in many regions 
(161)
; by issuing 
a report on the Cochrane reviews of supplementation only, this statement missed an 
opportunity to address the most critical concerns. Public health measures, such as food 
fortification with vitamin D, would benefit the population as a whole, including women prior 
to and during pregnancy, by increasing vitamin D in the food supply, raising vitamin D 






Deficiencies of iron, iodine and vitamin D are common, have multifactorial dietary and non-
nutritional risk factors and overlap in their contribution to adverse clinical outcomes, 
including neurological development in children, which impacts life chances. The adverse 
effects of poor-quality diets, with limited availability of micronutrients, are compounded by 
increasing rates of obesity among young women, with consequent inflammatory and 
metabolic disorders, all implicated in iron and vitamin D deficiencies and interlinked in the 
pathways for suboptimal neural development.  
 
Public health strategies are urgently required to improve the overall health and nutritional 
status of women of reproductive age. Strategies encompassing obesity prevention and early 
detection of malnutrition are required. Standardised screening including clinical risk factors 
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and indices of iron status would detect pregnant women at increased risk of iron deficiency. 
Development of sensitive, individual biomarkers of iodine status are needed for inclusion of 
iodine to screening strategies, with the dual purpose of protecting the health of the mother 
and fetal/infant brain development. Risk assessments of vitamin D requirements during 
pregnancy need to be revisited from the perspective of fetal and neonatal requirements. 
International consensus on standardised approaches to micronutrient assessment, analysis and 
reporting as well as sensitive, clinically-validated infant and child neuro-behavioural 
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Table 1 Dietary reference values for iron, iodine and vitamin D in pregnant and non-










   
 
Iron    
 Pregnant women 14.8 mg  16 mg 27 mg - 
Non-pregnant, non-lactating women 14.8 mg 16 mg 18 mg 19.6 mg 
 
    
Iodine     
Pregnant women 140 µg 200 µg * 220 µg 250 µg 
Non-pregnant, non-lactating women 140 µg 150 µg * 150 µg 150 µg 
 
    
Vitamin D     
Pregnant women 10 µg 15 µg* 15 µg 5 µg 
Non-pregnant, non-lactating women 10 µg 15 µg* 15 µg 5 µg 
Dietary reference values presented are RDA/RNI/PRI values 
* Adequate Intake 
Scientific Advisory Committee for Nutrition (SACN) 
(17, 162, 152)
; European Food Safety Authority 
(EFSA) 
(18, 163, 154)
; Institutes of Medicine (IOM) 
(21, 153)
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 Main direct effect of iron is on the synthesis of the 
monoamine neurotransmitters: dopamine, serotonin and 
norepinephrine. Monoamine synthesis begins in mid-
gestation, until about 3 years of age. 
 Altered monoamine metabolism results in disturbed sleep 
cycles, motor control, memory and social-emotional 
development. 
Energy Metabolism  Iron deficiency affects neuronal energy metabolic balance, 
especially in the hippocampus, the region responsible for 
recognition memory processing and other cognitive functions. 
 Disrupted energy metabolism results in abnormal branching of 
dendrites and synapse formation, leading to long-lasting 
morphological changes. 
Myelination   Iron deficiency, particularly in the late fetal and early 
childhood period, results in hypomyelination, a decrease in the 
production and quality of myelin, the fatty acid sheath 
surrounding neurons. 
 Hypomyelination impacts all brain regions, but disturbances 
in the auditory and visual systems of infants have been most 
closely linked to impaired myelination. 
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